Welcome to ImmunoSYS
INNOVATIVE IMMUNOLOGY & BIO-ANALYSIS
ImmunoSYS is an analytical service providing company specialising in immunologic and ultra-sensitive assays. We bring innovative solutions to biological analysis.
- Are you involved in large molecules drug discovery?
- Does your work involve proteins and the interaction with the immune system?
- Is ‘Immunogenicity’ a concern in your work?
We have novel approaches in immunology that could help your work significantly.
The preclinical stage of drug development is a critical phase that takes a new investigational drug through efficacy and safety tests in non-human studies to the human studies in clinical phase. Assays that can be predictive of outcomes in human trials are of highest priority. ImmunoSYS is focused in developing and providing solutions in the immunology of drugs at this stage. Our innovative platform of comprehensive immunologic and pharmacokinetic analyses is a step towards understanding the safety of drugs before they are studied in humans.
ImmunoSYS is recipient of a 2-year Eurostars R&D project grant in partnership with Abundnz BV (Netherlands). The project COMPIT started in Jan 2017 at the Alderley Park and is focused on studying the immunology of drug-induced tissue damage. The outcomes of the project is expected to develop a novel and robust preclinical in vitro cellular system for the analysis of immunological risk of drug compounds.